Autophagy inhibition enhances the inhibitory effects of ursolic acid on lung cancer cells.
Int J Mol Med
; 46(5): 1816-1826, 2020 Nov.
Article
em En
| MEDLINE
| ID: mdl-32901853
ABSTRACT
The aim of the present study was to identify natural compounds that bear significant antitumor activity. Thus, the effects of 63 small molecules that were isolated from traditional Chinese medicinal herbs on A549 human nonsmall cell lung cancer (NSCLC) and MCF7 breast cancer cells were examined. It was found that ursolic acid (UA), a natural pentacyclic triterpenoid, exerted significant inhibitory effect on these cells. Further experiments revealed that UA inhibited the proliferation of various lung cancer cells, including the NSCLC cells, H460, H1975, A549, H1299 and H520, the human small cell lung cancer (SCLC) cells, H82 and H446, and murine Lewis lung carcinoma (LLC) cells. UA induced the apoptosis and autophagy of NSCLC cells. The inhibition of the mammalian target of rapamycin (mTOR) signaling pathway, but not the activation of the extracellular signalregulated kinase 1/2 (ERK1/2) signaling pathway contributed to the UAinduced autophagy of NSCLC cells. Moreover, the inhibition of autophagy by chloroquine (CQ) or siRNA for autophagyrelated gene 5 (ATG5) enhanced the UAinduced inhibition of cell proliferation and promotion of apoptosis, indicating that UAinduced autophagy is a prosurvival mechanism in NSCLC cells. On the whole, these findings suggest that combination treatment with autophagy inhibitors may be a novel strategy with which enhance the antitumor activity of UA in lung cancer.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Autofagia
/
Triterpenos
/
Neoplasias Pulmonares
Tipo de estudo:
Prognostic_studies
Limite:
Animals
/
Humans
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article